Constellium Se Financials
Constellium Se (CSTM) reported $8.9B in revenue over the twelve months to Mar 31, 2026, up 20.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Margin expansion and cash generation returned in FY2025, but capital reinvestment and leverage still shape Constellium's operations.
In FY2025, earnings quality improved: net income of$273M was accompanied by operating cash flow of$489M , a much closer profit-to-cash relationship than in FY2024. Yet capital intensity remains material:$330M of capital spending left free cash flow at$159M , meaning much of the operating cash was reinvested before financing decisions.
The top-line recovery in FY2025 came with gross margin of
Debt-to-equity fell to 2.0x from 2.7x, pointing to a larger equity cushion rather than a clean debt exit. Current ratio stayed near 1.3x even as buybacks reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Constellium Se's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Constellium Se, and counted as zero in the overall score.
Constellium Se's revenue surged 15.2% year-over-year to $8.4B, reflecting rapid business expansion. This strong growth earns a score of 45/100.
Constellium Se has a moderate D/E ratio of 2.00. This balance of debt and equity financing earns a leverage score of 30/100.
Constellium Se's current ratio of 1.29 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.
Constellium Se has a free cash flow margin of 1.9%, earning a moderate score of 31/100. The company generates positive cash flow after capital investments, but with room for improvement.
Not available for Constellium Se, and counted as zero in the overall score.
Constellium Se passes 9 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Constellium Se generates $1.79 in operating cash flow ($489.0M OCF vs $273.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Constellium Se generated $8.4B in revenue in fiscal year 2025. This represents an increase of 15.2% from the prior year.
Constellium Se reported $273.0M in net income in fiscal year 2025. This represents an increase of 387.5% from the prior year.
Constellium Se earned $1.92 per diluted share (EPS) in fiscal year 2025. This represents an increase of 405.3% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Constellium Se generated $159.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 242.0% from the prior year.
Constellium Se held $120.0M in cash against $1.9B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Constellium Se's gross margin was 14.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.3 percentage points from the prior year.
Constellium Se's net profit margin was 3.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.5 percentage points from the prior year.
Constellium Se's ROE was 28.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 20.8 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Constellium Se invested $51.0M in research and development in fiscal year 2025. This represents an increase of 4.1% from the prior year.
Constellium Se spent $115.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 45.6% from the prior year.
Constellium Se invested $330.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 20.1% from the prior year.
CSTM Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B+11.8% | $2.2B+1.6% | $2.2B+3.0% | $2.1B+6.3% | $2.0B+15.0% | $1.7B-4.5% | $1.8B-6.7% | $1.9B |
| Cost of Revenue | $2.0B+10.1% | $1.9B+0.1% | $1.9B+0.7% | $1.8B+7.2% | $1.7B+13.4% | $1.5B-5.3% | $1.6B-3.3% | $1.7B |
| Gross Profit | $420.0M+21.0% | $347.0M+10.5% | $314.0M+19.4% | $263.0M0.0% | $263.0M+26.4% | $208.0M+1.5% | $205.0M-26.8% | $280.0M |
| R&D Expenses | $13.0M-7.1% | $14.0M+16.7% | $12.0M0.0% | $12.0M-7.7% | $13.0M+30.0% | $10.0M-9.1% | $11.0M-15.4% | $13.0M |
| SG&A Expenses | $97.0M+19.8% | $81.0M-4.7% | $85.0M-3.4% | $88.0M+12.8% | $78.0M-15.2% | $92.0M+39.4% | $66.0M-12.0% | $75.0M |
| Interest Expense | $26.0M+4.0% | $25.0M-7.4% | $27.0M+8.0% | $25.0M0.0% | $25.0M-7.4% | $27.0M+8.0% | $25.0M+13.6% | $22.0M |
| Income Tax | $76.0M+49.0% | $51.0M+34.2% | $38.0M+90.0% | $20.0M-16.7% | $24.0M-17.2% | $29.0M+163.6% | $11.0M-59.3% | $27.0M |
| Net Income | $199.0M+77.7% | $112.0M+27.3% | $88.0M+144.4% | $36.0M-2.7% | $37.0M+177.1% | -$48.0M-785.7% | $7.0M-90.8% | $76.0M |
| EPS (Diluted) | $1.42+79.7% | $0.79+27.4% | $0.62+148.0% | $0.25-3.8% | $0.26+181.3% | -$0.32-740.0% | $0.05-90.2% | $0.51 |
Not reported in any period shown, so not listed: Operating Income.
CSTM Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.8B+9.2% | $5.4B-0.4% | $5.4B+0.1% | $5.4B+3.9% | $5.2B+9.2% | $4.7B | N/A | N/A |
| Current Assets | $3.0B+27.1% | $2.3B-1.3% | $2.4B+1.8% | $2.3B+3.4% | $2.2B+21.9% | $1.8B | N/A | N/A |
| Cash & Equivalents | $143.0M+19.2% | $120.0M-1.6% | $122.0M-8.3% | $133.0M+12.7% | $118.0M-16.3% | $141.0M-17.1% | $170.0M-25.4% | $228.0M |
| Inventory | $1.7B+18.8% | $1.4B+3.0% | $1.4B+2.9% | $1.3B+3.9% | $1.3B+8.2% | $1.2B | N/A | N/A |
| Accounts Receivable | $853.0M+39.6% | $611.0M-11.8% | $693.0M+2.1% | $679.0M+2.1% | $665.0M+74.5% | $381.0M | N/A | N/A |
| Goodwill | $47.0M0.0% | $47.0M0.0% | $47.0M0.0% | $47.0M+2.2% | $46.0M0.0% | $46.0M | N/A | N/A |
| Total Liabilities | $4.7B+7.5% | $4.4B-2.9% | $4.5B-1.2% | $4.6B+3.8% | $4.4B+9.9% | $4.0B | N/A | N/A |
| Current Liabilities | $2.1B+17.8% | $1.8B-2.4% | $1.8B-1.7% | $1.9B+3.6% | $1.8B+25.0% | $1.4B | N/A | N/A |
| Long-Term Debt | $1.9B+1.7% | $1.9B-3.5% | $2.0B+0.1% | $2.0B+3.4% | $1.9B+1.5% | $1.9B | N/A | N/A |
| Total Equity | $1.1B+17.5% | $952.0M+12.7% | $845.0M+8.3% | $780.0M+4.7% | $745.0M+5.5% | $706.0M-12.2% | $804.0M+1.0% | $796.0M |
| Retained Earnings | $529.0M+49.4% | $354.0M | N/A | N/A | N/A | $93.0M | N/A | N/A |
CSTM Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $73.0M-66.5% | $218.0M+120.2% | $99.0M-13.2% | $114.0M+96.6% | $58.0M-4.9% | $61.0M-6.2% | $65.0M-52.9% | $138.0M |
| Capital Expenditures | $72.0M-33.9% | $109.0M+45.3% | $75.0M-2.6% | $77.0M+11.6% | $69.0M-54.3% | $151.0M+45.2% | $104.0M+23.8% | $84.0M |
| Free Cash Flow | $1.0M-99.1% | $109.0M+354.2% | $24.0M-35.1% | $37.0M+436.4% | -$11.0M+87.8% | -$90.0M-130.8% | -$39.0M-172.2% | $54.0M |
| Investing Cash Flow | -$68.0M+37.6% | -$109.0M-58.0% | -$69.0M+4.2% | -$72.0M-22.0% | -$59.0M+52.8% | -$125.0M-62.3% | -$77.0M-26.2% | -$61.0M |
| Financing Cash Flow | $20.0M+117.9% | -$112.0M-173.2% | -$41.0M-13.9% | -$36.0M-38.5% | -$26.0M-157.8% | $45.0M+181.8% | -$55.0M-34.1% | -$41.0M |
| Share Buybacks | $28.0M-30.0% | $40.0M+60.0% | $25.0M-28.6% | $35.0M+133.3% | $15.0M-21.1% | $19.0M-9.5% | $21.0M-34.4% | $32.0M |
Not reported in any period shown, so not listed: Dividends Paid.
CSTM Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.1%+1.3pp | 15.8%+1.3pp | 14.5%+2.0pp | 12.5%-0.8pp | 13.3%+1.2pp | 12.1%+0.7pp | 11.4%-3.1pp | 14.5% |
| Net Margin | 8.1%+3.0pp | 5.1%+1.0pp | 4.1%+2.3pp | 1.7%-0.2pp | 1.9%+4.7pp | -2.8%-3.2pp | 0.4%-3.5pp | 3.9% |
| Return on Equity | 17.8%+6.0pp | 11.8%+1.3pp | 10.4%+5.8pp | 4.6%-0.4pp | 5.0%+11.8pp | -6.8%-7.7pp | 0.9%-8.7pp | 9.6% |
| Return on Assets | 3.4%+1.3pp | 2.1%+0.4pp | 1.6%+1.0pp | 0.7%0.0pp | 0.7%+1.7pp | -1.0% | N/A | N/A |
| Current Ratio | 1.39+0.1x | 1.290.0x | 1.280.0x | 1.230.0x | 1.240.0x | 1.27 | N/A | N/A |
| Debt-to-Equity | 1.73-0.3x | 2.00-0.3x | 2.34-0.2x | 2.530.0x | 2.56-0.1x | 2.66 | N/A | N/A |
| FCF Margin | 0.0%-4.9pp | 5.0%+3.8pp | 1.1%-0.7pp | 1.8%+2.3pp | -0.6%+4.7pp | -5.2%-3.1pp | -2.2%-5.0pp | 2.8% |
Not reported in any period shown, so not listed: Operating Margin.
Similar Companies
Where Constellium Se Ranks
Frequently Asked Questions
What is Constellium Se's annual revenue?
Constellium Se (CSTM) reported $8.4B in total revenue for fiscal year 2025. This represents a 15.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Constellium Se's revenue growing?
Constellium Se (CSTM) revenue grew by 15.2% year-over-year, from $7.3B to $8.4B in fiscal year 2025.
Is Constellium Se profitable?
Yes, Constellium Se (CSTM) reported a net income of $273.0M in fiscal year 2025, with a net profit margin of 3.2%.
How much debt does Constellium Se have?
As of fiscal year 2025, Constellium Se (CSTM) had $120.0M in cash and equivalents against $1.9B in long-term debt.
What is Constellium Se's gross margin?
Constellium Se (CSTM) had a gross margin of 14.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Constellium Se's net profit margin?
Constellium Se (CSTM) had a net profit margin of 3.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Constellium Se's return on equity (ROE)?
Constellium Se (CSTM) has a return on equity of 28.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Constellium Se's free cash flow?
Constellium Se (CSTM) generated $159.0M in free cash flow during fiscal year 2025. This represents a 242.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Constellium Se's operating cash flow?
Constellium Se (CSTM) generated $489.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Constellium Se's total assets?
Constellium Se (CSTM) had $5.4B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Constellium Se's capital expenditures?
Constellium Se (CSTM) invested $330.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Constellium Se spend on research and development?
Constellium Se (CSTM) invested $51.0M in research and development during fiscal year 2025.
What is Constellium Se's current ratio?
Constellium Se (CSTM) had a current ratio of 1.29 as of fiscal year 2025, which is considered adequate.
What is Constellium Se's debt-to-equity ratio?
Constellium Se (CSTM) had a debt-to-equity ratio of 2.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Constellium Se's return on assets (ROA)?
Constellium Se (CSTM) had a return on assets of 5.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Constellium Se's Piotroski F-Score?
Constellium Se (CSTM) has a Piotroski F-Score of 9 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Constellium Se's earnings high quality?
Constellium Se (CSTM) has an earnings quality ratio of 1.79x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Constellium Se?
Constellium Se (CSTM) scores 23 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.